Literature DB >> 15128865

Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.

Diana Gubisne-Haberle1, Wayne Hill, Mychaylo Kazachkov, J Steven Richardson, Peter H Yu.   

Abstract

Semicarbazide-sensitive amine oxidase (SSAO) catalyzes the conversion of methylamine to formaldehyde. This enzyme is located on the surface of the cytoplasmic membrane and in the cytosol of vascular endothelial cells, smooth muscle cells, and adipocytes. Increased SSAO activity has been found in patients with diabetes mellitus, chronic heart failure, and multiple types of cerebral infarcts and is associated with obesity. Increased SSAO-mediated deamination may contribute to protein deposition, the formation of plaques, and inflammation, and thus may be involved in the pathophysiology of chronic vascular and neurological disorders, such as diabetic complications, atherosclerosis, and Alzheimer's disease. In the present study, we demonstrate the induction of cross-linkage of formaldehyde with the lysine moiety of peptides and proteins. Formaldehyde-protein adducts were reduced with sodium cyanoborohydride, hydrolyzed in hydrochloric acid, and the amino acids in the hydrolysates were derivatized with fluorenylmethyl chloroformate and then identified with high-performance liquid chromatography. We further demonstrate that incubation of methylamine in the presence of SSAO-rich tissues, e.g., human brain meninges, results in formaldehyde-protein cross-linkage of particulate bound proteins as well as of soluble proteins. This cross-linkage can be completely blocked by a selective inhibitor of SSAO. Our data support the hypothesis that the SSAO-induced production of formaldehyde may be involved in the alteration of protein structure, which may subsequently cause protein deposition associated with chronic pathological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128865     DOI: 10.1124/jpet.104.068601

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

Review 2.  Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Jacqueline R Kulbe; Edward D Hall
Journal:  Exp Neurol       Date:  2020-04-20       Impact factor: 5.330

3.  Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease.

Authors:  K Chen; M Kazachkov; P H Yu
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

4.  Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.

Authors:  M Unzeta; M Solé; M Boada; M Hernández
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

Review 5.  Amine oxidase substrates for impaired glucose tolerance correction.

Authors:  C Carpéné; S Bour; V Visentin; F Pellati; S Benvenuti; M C Iglesias-Osma; M J García-Barrado; P Valet
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

6.  Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.

Authors:  Peter H Yu; Li-Xin Lu; Hui Fan; Mychaylo Kazachkov; Zhong-Jian Jiang; Sirpa Jalkanen; Craig Stolen
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

7.  Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats.

Authors:  Zs Soltész; T Tábi; A S Halász; M Pálfi; E Kocsis; K Magyar; M Tóth; E Szökö
Journal:  J Neural Transm (Vienna)       Date:  2007-04-13       Impact factor: 3.575

8.  Effects of Phenelzine Administration on Mitochondrial Function, Calcium Handling, and Cytoskeletal Degradation after Experimental Traumatic Brain Injury.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2018-12-12       Impact factor: 5.269

9.  Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.

Authors:  Dmitriy Matveychuk; Emerson Nunes; Nasir Ullah; Carlos A Velázquez-Martinez; Erin M MacKenzie; Glen B Baker
Journal:  J Neural Transm (Vienna)       Date:  2013-02-08       Impact factor: 3.575

10.  Exploring the roles of the metal ions in Escherichia coli copper amine oxidase.

Authors:  Mark A Smith; Pascale Pirrat; Arwen R Pearson; Christian R P Kurtis; Chi H Trinh; Thembaninkosi G Gaule; Peter F Knowles; Simon E V Phillips; Michael J McPherson
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.